Fig. 1From: Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directionsProposed treatment algorithm of adult ALL according to MRD status. ALL, acute lymphoblastic leukemia; MRD, measurable residual disease; Ph, Philadelphia-chromosome; HSCT, hematopoietic stem cell transplant; CMR, complete molecular response; TKI, tyrosine kinase inhibitor; ETP, early T cell precursorBack to article page